1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline.
2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults.
3. Imbruvica in combination with obinutuzumab is the first nonchemotherapy treatment regimen for some patients with chronic lymphocytic leukemia.
4. Tremfya is now available in a patient-controlled injector formulation to treat psoriasis.
5. Alimta may now be used in combination with Keytruda as a first-line treatment for patients with metastatic, nonsquamous non-small-cell lung cancer.
More articles on supply chain:
Flu season, winter storms cause low blood supplies in Ohio
Verily’s smartwatch gets FDA clearance for EKG: 4 things to know
23andMe gets FDA approval for another direct-to-consumer cancer test
